SCHEMBL7948487

SCHEMBL7948487

CNCc1c(C)ccc2[nH]c(=O)c(=O)[nH]c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.44
GRIN2D O15399 3/20 0.44
GRIN3B O60391 3/20 0.44
GRIN1 Q05586 3/20 0.44
GRIN2A Q12879 3/20 0.44
GRIN2B Q13224 3/20 0.44
GRIN2C Q14957 3/20 0.44
GRIN3A Q8TCU5 3/20 0.44
KDM4E B2RXH2 4/20 0.44
ALDH1A1 P00352 4/20 0.44
LMNA P02545 3/20 0.37
GRIA1 P42261 2/20 0.36
GRIA2 P42262 2/20 0.36
GRIA3 P42263 2/20 0.36
GRIA4 P48058 2/20 0.36
HPGD P15428 2/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GAA P10253 2/20 0.35
GRIK1 P39086 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8169596 0.84 HSD17B10 (0.42) HSD17B10GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL8656635 0.82 KDM4E (0.43) HSD17B10GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL8634867 0.77 GRIN2D (0.44) HSD17B10GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL7957683 0.72 GRIN2D (0.50) HSD17B10GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL8037105 0.72 CFB (0.48) HSD17B10GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL8037118 0.71 CFB (0.50) HSD17B10KDM4EALDH1A1HPGDMAPT
SCHEMBL8040463 0.71 CFB (0.50) HSD17B10KDM4EALDH1A1HPGDMAPT
SCHEMBL7521972 0.70 KDM4E (0.53) HSD17B10GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL8037080 0.70 HSD17B10 (0.38) HSD17B10GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL499361 0.70 GRIN2D (0.55) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6268366-B1 Amide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists WARNER-LAMBERT COMPANY 2001-07-31 US disclosed
US-6191134-B1 STROKE THERAPY, ANTIISCHEMIC AGENTS, BRAIN DISORDERS WARNER-LAMBERT COMPANY 2001-02-20 US disclosed
US-6172065-B1 CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY 2001-01-09 US disclosed
US-6096744-A ANTICONVULSANTS WARNER-LAMBERT COMPANY (US) 2000-08-01 US disclosed
US-6063774-A NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 2000-05-16 US disclosed
WO-1998023599-A1 UREA AND THIOUREA DERIVATIVES OF SUBSTITUTED QUINOXALINE 2,3-DIONES AS GLUTAMATE RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-06-04 WO disclosed
WO-1997046539-A1 AMIDE DERIVATIVES OF SUBSTITUTED QUINOXALINE 2,3-DIONES AS GLUTAMATE RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-12-11 WO disclosed